Results 31 to 40 of about 724,197 (388)
The Anticoagulant and Nonanticoagulant Properties of Heparin
Thrombosis and Haemostasis, 2020 Heparins represent one of the most frequently used pharmacotherapeutics. Discovered around 1926, routine clinical anticoagulant use of heparin was initiated only after the publication of several seminal papers in the early 1970s by the group of Kakkar ...
D. Beurskens +5 more
semanticscholar +1 more source
Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
Frontiers in Molecular Biosciences, 2022 Heparan sulfate (HS) acts as a co-receptor of angiotensin-converting enzyme 2 (ACE2) by interacting with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein (SGP) facilitating host cell entry of SARS-CoV-2 virus ...
Adrianne L. Gelbach +11 more
doaj +1 more source
Interaction of antithrombin III with surface-immobilized albumin-heparin conjugates [PDF]
, 1995 The interaction between antithrombin III (ATIII) and albumin-heparin conjugates covalently coupled onto carboxylated polystyrene beads either in buffer containing albumin or in plasma was studied using 14C-labeled ATIII.
Delden, C.J. van +2 more
core +3 more sources
Our experience of coronary angiography with and without heparin
Indian Heart Journal, 2012 Aim: Coronary angiography is usually done with heparin. Our aim is to see whether it can be done without heparin through femoral route and its effect on local complications.
Goutam Datta +5 more
doaj +1 more source
Heparin and air filters reduce embolic events caused by intra-arterial cerebral angiography - A prospective, randomized trial [PDF]
, 2004 Background-Intra-arterial cerebral angiography is associated with a low risk for neurological complications, but clinically silent ischemic events after angiography have been seen in a substantial number of patients.Methods and Results-In a prospective ...
Bartsch, AJ +8 more
core +1 more source
Design of a new type of coating for the controlled release of heparin [PDF]
, 1997 Thrombus formation at the surface of blood contacting devices can be prevented by local release of heparin. Preferably, the release rate should be constant for prolonged periods of time.
Engbers, G.H.M. +4 more
core +3 more sources
Heparin-induced thrombocytopenia among patients of a comprehensive cancer center
SAGE Open Medical Case Reports, 2014 Most clinical studies of heparin-induced thrombocytopenia have not included cancer patients who have high risk of thromboembolism, frequent exposure to heparin, and many potential causes of thrombocytopenia other than heparin-induced thrombocytopenia. To
Weixin Wu +5 more
doaj +1 more source
Adriamycin loading and release characteristics of albumin-heparin conjugate microspheres [PDF]
, 1994 Biodegradable ion-exchange microspheres, prepared from a prefabricated conjugate of albumin and heparin were investigated as carriers for adriamycin. The ion-exchange microspheres could be loaded with adriamycin giving payloads up to 33% w/w, depending ...
Bae, Y.H. +6 more
core +2 more sources
IJU Case Reports, 2020 Introduction Heparin‐induced thrombocytopenia is an antibody‐mediated acquired prothrombotic state induced by heparin exposure. The risk of thromboembolic diseases in kidney transplantation with heparin‐induced thrombocytopenia without perioperative ...
Hayato Nishida +9 more
doaj +1 more source